Literature DB >> 3000127

Accumulation of amyloid in pituitary adenomas.

Y Saitoh, H Mori, K Matsumoto, Y Ushio, T Hayakawa, S Mori, N Arita, H Mogami.   

Abstract

The accumulation of amyloid in pituitary adenomas was examined in relation to the types of adenoma and the effect of bromocriptine treatment. Amyloid had accumulated in 34 of 48 adenomas (71%). The occurrence in prolactin-secreting adenomas and growth hormone-secreting adenomas was 79%, respectively, while that in non-functioning adenomas was 50%. Treatment with bromocriptine enhanced the occurrence and extent of the amyloid accumulation in prolactin- or growth hormone-secreting adenomas. Electron microscopy revealed the initial appearance of the amyloid fibrils in the smooth endoplasmic reticulum and a possible sequential process of their release from the cells. The presence of secretory granules in vesicles containing amyloid fibrils and their simultaneous release with amyloid fibrils suggested that degradation of secretory granules was involved in the formation of amyloid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000127     DOI: 10.1007/bf00688628

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  22 in total

1.  Amyloidosis of functioning islet cell adenomas of the pancreas.

Authors:  E A PORTA; R YERRY; R F SCOTT
Journal:  Am J Pathol       Date:  1962-11       Impact factor: 4.307

Review 2.  Ultrastructure of human sella tumors. Correlations of clinical findings and morphology.

Authors:  A M Landolt
Journal:  Acta Neurochir (Wien)       Date:  1975       Impact factor: 2.216

3.  Amyloid in polypeptide hormone-producing tumors.

Authors:  P Westermark; L Grimelius; J M Polak; L I Larsson; S Van Noorden; E Wilander; A G Pearse
Journal:  Lab Invest       Date:  1977-08       Impact factor: 5.662

4.  Intrasellar amyloid tumor.

Authors:  R Barr; P Lampert
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

Review 5.  ACTH, beta-lipotropin, and related peptides in brain, pituitary, and blood.

Authors:  D T Krieger; A S Liotta; M J Brownstein; E A Zimmerman
Journal:  Recent Prog Horm Res       Date:  1980

6.  Pituitary adenoma producing amyloid-like substance.

Authors:  J M Bilbao; E Horvath; A R Hudson; K Kovacs
Journal:  Arch Pathol       Date:  1975-08

7.  Prolactinoma of pituitary with associated amyloid-like substances. Case report.

Authors:  J Kuratsu; Y Matsukado; M Miura
Journal:  J Neurosurg       Date:  1983-12       Impact factor: 5.115

8.  Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.

Authors:  H Mori; S Mori; Y Saitoh; N Arita; T Aono; T Uozumi; H Mogami; K Matsumoto
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

9.  Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations.

Authors:  J H Guyda
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

10.  Growth hormone-producing pituitary adenoma with crystal-like amyloid immunohistochemically positive for growth hormone.

Authors:  H Mori; S Mori; Y Saitoh; K Moriwaki; S Iida; K Matsumoto
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

View more
  10 in total

1.  MR imaging characteristics of amyloid deposits in pituitary adenoma.

Authors:  Steven W Martin; Daniel R Lefton; Richard S Pinto; Marc Rosenblum; Eric Elowitz
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  Calcified Prolactinoma of the Pituitary Gland: Illustrative Case Reports Highlighting Medical versus Surgical Intervention.

Authors:  Sherwin Tavakol; Asma Hasan; Michelle A Wedemeyer; Joshua Bakhsheshian; Chia-Shang J Liu; Mark S Shiroishi; Anna Mathew; John D Carmichael; Gabriel Zada
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-05

Review 3.  Clinical Impact of the Current WHO Classification of Pituitary Adenomas.

Authors:  W Saeger; J Honegger; M Theodoropoulou; U J Knappe; C Schöfl; S Petersenn; R Buslei
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

4.  Prolactin-derived amyloid in the aging pituitary gland.

Authors:  P Westermark; L Eriksson; U Engström; S Eneström; K Sletten
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

Review 5.  Amyloid deposits in a prolactin-producing pituitary adenoma.

Authors:  P L Bononi; A J Martinez; P B Nelson; J A Amico
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

6.  Pituicytoma with gelsolin amyloid deposition.

Authors:  Cristiane M Ida; Xiaoling Yan; Mark E Jentoft; N Sertac Kip; Bernd W Scheithauer; Jonathan M Morris; Ahmet Dogan; Joseph E Parisi; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

7.  Basement membrane proteins and apolipoprotein E in growth hormone secreting adenomas and their correlation to amyloid: an immunoelectron microscopic study.

Authors:  K Steusloff; C Röcken; W Saeger
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

8.  Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis.

Authors:  T D O'Brien; P C Butler; D K Kreutter; L A Kane; N L Eberhardt
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  Extensive spherical amyloid deposition presenting as a pituitary tumor.

Authors:  P Wiesli; M Brändle; S Brandner; S S Kollias; R L Bernays
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

10.  Pituitary Prolactinoma with Amyloid Deposits: Surgery or Dopamine Agonists? Review of Previous Reports and New Recommendations for Management.

Authors:  Santosh Prabhu; Sujata Prabhu
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.